Boai NKY Pharmaceuticals Ltd Market Cap ($913.34 Million)
Market Cap & Net Worth: Boai NKY Pharmaceuticals Ltd (300109)
Boai NKY Pharmaceuticals Ltd market cap. Boai NKY Pharmaceuticals Ltd (SHE:300109) has a market capitalization of $913.34 Million (CN¥6.24 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #8996 globally and #2143 in its home market, demonstrating a 0.46% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Boai NKY Pharmaceuticals Ltd's stock price CN¥10.82 by its total outstanding shares 576856526 (576.86 Million). Also see 300109 cash flow metrics for how efficiently the company converts equity into cash flow.
Boai NKY Pharmaceuticals Ltd Market Cap History (2015–2026)
Boai NKY Pharmaceuticals Ltd market cap history from 2015 to 2026. Data shows change from $5.95 Billion to $913.34 Million (-10.55% CAGR). Check Boai NKY Pharmaceuticals Ltd stock quote for real-time trading data and today's change.
Boai NKY Pharmaceuticals Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Boai NKY Pharmaceuticals Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 300109 shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.20x
Boai NKY Pharmaceuticals Ltd's market cap is 1.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
7.46x
Boai NKY Pharmaceuticals Ltd's market cap is 7.46 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.80 Billion | $400.62 Million | $80.04 Million | 6.99x | 34.97x |
| 2017 | $2.67 Billion | $488.58 Million | $92.82 Million | 5.46x | 28.74x |
| 2018 | $1.03 Billion | $698.28 Million | $89.55 Million | 1.48x | 11.50x |
| 2019 | $1.23 Billion | $924.43 Million | $122.80 Million | 1.33x | 10.02x |
| 2020 | $1.03 Billion | $978.53 Million | $44.57 Million | 1.05x | 23.13x |
| 2021 | $1.64 Billion | $1.22 Billion | $207.05 Million | 1.35x | 7.93x |
| 2022 | $1.87 Billion | $1.49 Billion | $291.46 Million | 1.26x | 6.40x |
| 2023 | $1.41 Billion | $1.58 Billion | $493.03 Million | 0.89x | 2.85x |
| 2024 | $1.35 Billion | $1.61 Billion | $349.68 Million | 0.84x | 3.85x |
| 2025 | $1.42 Billion | $1.18 Billion | $190.09 Million | 1.20x | 7.46x |
Competitor Companies of 300109 by Market Capitalization
Companies near Boai NKY Pharmaceuticals Ltd in the global market cap rankings as of November 5, 2026. Also see how large is Boai NKY Pharmaceuticals Ltd's balance sheet for a full breakdown of the balance sheet.
Key companies related to Boai NKY Pharmaceuticals Ltd by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #94 globally with a market cap of $215.12 Billion USD.
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #240 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Air Liquide SA (PA:AI): Ranked #251 globally with a market cap of $101.06 Billion USD ( €86.44 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #291 globally with a market cap of $89.91 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #94 | Linde plc Ordinary Shares | NASDAQ:LIN | $215.12 Billion | $524.74 |
| #240 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #251 | Air Liquide SA | PA:AI | $101.06 Billion | €187.36 |
| #291 | Sherwin-Williams Co | NYSE:SHW | $89.91 Billion | $363.50 |
Market Capitalization of Boai NKY Pharmaceuticals Ltd (2015–2026)
Market capitalization of Boai NKY Pharmaceuticals Ltd from 2015 to today. Between 2015 and today, Boai NKY Pharmaceuticals Ltd's market cap moved from $5.95 Billion to $ 913.34 Million, with a yearly change of -10.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥913.34 Million | -35.56% |
| 2025 | CN¥1.42 Billion | +5.27% |
| 2024 | CN¥1.35 Billion | -4.34% |
| 2023 | CN¥1.41 Billion | -24.54% |
| 2022 | CN¥1.87 Billion | +13.57% |
| 2021 | CN¥1.64 Billion | +59.27% |
| 2020 | CN¥1.03 Billion | -16.24% |
| 2019 | CN¥1.23 Billion | +19.50% |
| 2018 | CN¥1.03 Billion | -61.39% |
| 2017 | CN¥2.67 Billion | -4.69% |
| 2016 | CN¥2.80 Billion | -52.93% |
| 2015 | CN¥5.95 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Boai NKY Pharmaceuticals Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $913.34 Million USD |
| MoneyControl | $913.34 Million USD |
| MarketWatch | $913.34 Million USD |
| marketcap.company | $913.34 Million USD |
| Reuters | $913.34 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Boai NKY Pharmaceuticals Ltd
Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP) series products, vinyl methyl ether/maleic anhydride copolymer (PVM/MA, Euroster) copolymer, and oral care products; and medical technology services, such as early tumor screening, molecular diagnostics, and precisio… Read more